SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Reactive Biosciences
Reactive Bioscience is using the world’s leading boron-based discovery platform to discover and develop medicines in innovative and imaginative new ways.
Website
